News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Do Patents Promote or Stall Innovation?
Catherine Offord | May 31, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Picks: January 29, 2014
Tracy Vence | Jan 29, 2015
Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish
Another Legal Setback for Myriad
Kerry Grens | Mar 11, 2014
A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.
Week in Review, June 17–21
Jef Akst | Jun 21, 2013
On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity
Opinion: On Patenting Genes
Joan Ellis | Jun 18, 2013
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Week in Review, June 10–14
Bob Grant | Jun 14, 2013
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
Should Human Genes be Patented?
Edyta Zielinska | Dec 3, 2012
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Court Rules Gene Patents Valid
Cristina Luiggi | Aug 17, 2012
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
Watson Opposes Gene Patents
Jef Akst | Jul 19, 2012
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.
Gene Patents Back in Court
Cristina Luiggi | Jun 19, 2012
A public interest legal group has renewed the fight against DNA patenting.